We have isolated mutants resistant to acidomycin, a biotin analog, from Serratia narcescens Sr41. Strain SB304, resistant to 0.5 mg of acidomycin (frequently called actithiazic acid) per ml, produced 5 mg of D-biotin per liter of a medium containing sucrose and urea. Strain SB412, which was isolated from SB304 on a minimal agar plate containing 2 mg of acidomycin per ml and 0.1 mg of 5-(2-thienyl)-valeric acid per ml, produced 20 mg of D-biotin per ml. The two enzymes related to biotin synthesis were found to be released from biotin-mediated feedback repression in these mutants. Transductional analysis revealed that SB412 had acquired at least two mutations, one in the biotin operon locus and the other in an unknown locus distant from the biotin operon locus.
D-Biotin is widely distributed in plant and animal tissues, where it functions as the protein-bound cofactor for a variety of enzymatic carboxylation reactions. A resurgence of interest in the development of new methods for the production of this vitamin has been sparked by recent disclosures in the area of animal feed additives (11, 31, 47, 54) . At present, several chemical syntheses of D-biotin have been reported, but they require multistep processes because of the presence of three asymmetric carbons in D-biotin (23) . On the other hand, microbial production of D-biotin has been the subject of recent concern, but no biotechnological processes amenable to large-scale production have been reported to date (21, 26, 36, 42, 48, 55) .
A number of microorganisms synthesize D-biotin, although in a very small amount, but the biotin biosynthetic pathway is yet unclear except for a few enzymatic steps (18) . In microorganisms, D-biotin is synthesized from pimeloylcoenzyme A (pimeloyl-CoA) through four enzymatic steps (Fig. 1) . The precursors to pimeloyl-CoA are still unknown, whereas some microorganisms are reported to be capable of converting pimelic acid to pimeloyl-CoA (28, 29) . In Eschenichia coli, the biosynthetic pathway from pimeloyl-CoA to D-biotin includes 7-keto-8-aminopelargonic acid (KAPA), 7,8-diaminopelargonic acid (DAPA), and dethiobiotin as intermediates (18) . The final step in the biosynthesis remains to be elucidated because of the unusual nature of the transformation reaction and unknown source of the sulfur atom (15, 20, 45) .
Serratia marcescens is an enteric bacterium, a gramnegative facultatively anaerobic rod. This bacterium grows fast and produces a high cell yield in a simple medium owing to its very high sugar-assimilating activity. This characteristic is convenient for fermentative production. Various mutants of this bacterium have been used for the industrial production of L-amino acids at Tanabe Seiyaku Co., Ltd., since around 1960 (33, 34) . In addition, we can apply genetic recombination techniques to S. marcescens, namely, bacte-riophage-mediated transductional cross and recombinant DNA methods (37, 51) . These are advantages of using S. marcescens for the construction of industrial strains. We therefore intended to develop a practical fermentative process for D-biotin production by using S. marcescens.
Here we report the construction and characteristics of a D-biotin-overproducing strain of S. marcescens.
MATERIALS AND METHODS
Bacterial strains and media. The strains used were derivatives of S. marcescens Sr4l and E. coli K-12 (Table 1) . Nutrient broth, containing 0.5% glucose, 1.0% peptone, 0.3% meat extract, 1.0% yeast extract, and 0.5% NaCl, was used for mutagenesis and routine colony isolation. The minimal medium of Davis and Mingioli (14) was modified by omitting sodium citrate and increasing the glucose concentration to 0.5%. For the isolation of acidomycin-resistant mutants, a minimal medium containing 0.5% ammonium fumarate as a carbon source was used. The medium for D-biotin production contained 10% sucrose, 1.0% urea, 0.1% K2HPO4, 0.2% MgSO4 7H20, 0.01% FeSO4. 7H20, and 1% CaCO3.
Bioautography. For the identification of biotin-related compounds, paper chromatography was carried out with n-butanol-1 N HCl (6:1) as a solvent system. After being dried, the paper was placed onto the surface of minimal agar plates seeded with cells of Saccharomyces cerevisiae ATCC 7754 for the auxanographic identification of biotin intermediates, namely, DAPA and KAPA (38, 41 (49) . Total amounts of D-biotin plus dethiobiotin were assayed with C. tropicalis IFO 0058. The extent of the growth on dethiobiotin was very similar to that on D-biotin when each was fed to the assay medium in equal amounts. The approximate amount of dethiobiotin was calculated from the total amounts of D-biotin plus dethiobiotin and of D-biotin determined separately.
Biotin production. A loopful of cells grown on nutrient agar slants overnight was inoculated into 15 ml of medium in 500-ml Sakaguchi shaking flasks and incubated at 30°C with reciprocal shaking (140 rpm, 7-cm stroke). Growth was estimated by measuring theA660 of culture broth diluted with 0.1 N HCl to dissolve CaCO3 and is expressed as dry cell weight calculated from a standard curve.
RESULTS
Biotin degradation by S. marcescens. Some microorganisms degrade D-biotin to bisnorbiotin and tetranorbiotin via ,-oxidation (27) . When the wild strain of S. marcescens Sr4l was grown in a medium containing sucrose and urea in the presence of D-biotin at a concentration of 1 mg/liter, no decrease in the D-biotin concentration was detectable, indicating a lack of biotin-degrading activity.
Control of biotin synthesis in S. marcescens. In E. coli, the five biotin biosynthetic enzymes are encoded in the biotin operon locus and subjected to strict feedback repression by biotin (2, 18) . By using the wild strain of S. marcescens Sr4l and its biotin auxotroph, SI001, we examined the activities of the two biotin biosynthetic enzymes, DAPA aminotransferase and dethiobiotin synthetase, each of which corresponds to the bioA and bioD products in E. coli, respectively. Both activities were significantly reduced when the wild strain was grown in a medium supplemented with D-biotin at a concentration as low as 4 nM ( Table 2) . When a biotin auxotroph, SI001, was cultured in the presence of a limited amount of D-biotin, the amount of cell mass was reduced to half that resulting from a culture in the presence of an abundant amount of D-biotin, and the two enzyme activities were increased about 10-fold above those of the wild strain grown in the absence of D-biotin. Thus, S. marcescens was similar to E. coli in the strict feedback repression of biotin biosynthetic enzymes.
Effect of biotin analogs on the growth of S. marcescens. Several biotin analogs were reported to be used for selecting mutants lacking feedback repression of the biotin biosynthesis (19, 24, 25, 31, 55) . We therefore examined the effect of six analogs, a-dehydrobiotin, a-methylbiotin, homobiotin, norbiotin, 5-(2-thienyl)-valeric acid, and acidomycin on the growth of S. marcescens. When glucose was used as a carbon source, none of them inhibited the growth of S. marcescens at a concentration of 0.1 mg/ml. The sensitivity to amino acid analogs has been reported to be enhanced by (Table 3) . a-Dehydrobiotin, a-methylbiotin, norbiotin, and homobiotin had no inhibitory effect on the growth at 0.1 mg/ml even in a minimal medium containing fumarate as a carbon source. Hence, we used acidomycin as a tool for the selection of regulatory mutants. Isolation of acidomycin-resistant mutants. We first isolated mutants resistant to 0.5 mg of acidomycin per ml and examined them for D-biotin excretion by an auxanographic feeding test. Of several hundred mutants, five formed very large biotin halos and were further tested for D-biotin production by using a medium containing sucrose and urea. Among them, strain SB304 was found to show the highest production even when subcultured on nutrient agar slants three times. This strain formed much smaller colonies on both minimal and nutrient agar plates than the wild strain.
We tested SB304 for sensitivity to higher concentrations of acidomycin, and this mutant was found to be somewhat sensitive to 2 mg of this analog per ml. The growth inhibition was enhanced by the addition of 0.1 mg of 5-(2-thienyl)- ( Table 2 ). Ten-and 15-fold increases in the specific activities Biotin production by acidomycin-resistant mutants. Biotin of the two enzymes were observed, respectively, and both production by acidomycin-resistant mutants was examined enzymes were synthesized constitutively. by using a medium containing sucrose and urea (Table 4) .
Transductional analysis of mutations involved in biotin SB304, derived from the wild strain, produced 5 mg of overproduction. The biotin overproduction described above D-biotin per liter of the medium, which is an increase greater might have resulted from regulatory mutations at the prethan 5,000-fold in the production of D-biotin compared with sumptive biotin operon locus or at the locus of a repressor that of the wild strain. The six strains designated SB402, for the biotin operon or both. We analyzed the mutations SB403, SB406, SB407, SB410, and SB412, derived from carried by SB304 and SB412 through a transductional cross SB304 and resistant to a higher concentration of the analog, with generalized bacteriophage PS20 (Table 5 ). produced larger amounts of D-biotin than SB304. Of these S001 (bioB) was used as a recipient for phage grown on six strains, strain SB412 showed the highest production and SB304, and 100 Bio+ transductants were examined for constantly produced about 20 mg of D-biotin after 72 h of D-biotin excretion by the auxanographic feeding test. None incubation even if subjected to subculture three times. A of these transductants excreted D-biotin on the basis of the bioautographic study using S. cerevisiae as an indicator auxanographic feeding test. Ninety S1001 transductants, strain revealed that SB412 accumulated no detectable obtained from SB412 phage and tested, excreted D-biotin in amounts of biotin precursors other than dethiobiotin. In the a small amount. To quantitate the production, five of these medium in which SB412 was cultured, dethiobiotin was transductants were cultured in a medium containing sucrose detected by bioautography and the concentration was estiand urea and found to produce about 0.1 mg of D-biotin per a One hundred colonies found were tested for biotin excretion, which is an unselected marker, by an auxanographic feeding test. When colonies were found to excrete biotin, five colonies were purified and tested for biotin production by using a medium containing sucrose and urea. a Cultivation was performed in a medium containing 10% sucrose and 1% urea. b Acidomycin was dissolved in dimethyl sulfoxide and added to the above medium after autoclaving. c Total biotin compounds represent the total amount of biotin plus dethiobiotin.
liter. This was more than 100 times that of the wild-type strain, 8000, but much smaller than that of SB304. The dethiobiotin synthetase level in representative Bio+ transductants from SB412 phage was about three times as high as that of a control transductant obtained in a cross between SIO01 and 8000 phage. In E. coli K-12, several mutations resulting in D-biotin overproduction have been localized to the regulatory gene birA that maps near the metB and argE loci (3, 8, 18, 52) . Our strains were expected to have similar mutations enhancing biotin production in a similar fashion. We therefore isolated metB+ and argE+ transductants of the respective S. marcescens mutants, D-403 (metB) and D-443 (argE), after infection with SB412 phage and tested 100 transductants for D-biotin excretion. None of them excreted D-biotin.
To further examine the genetic profile of SB412, the biotin operon locus of this strain was replaced with that of the wild type through a transductional cross. First, a biotin-requiring strain was isolated from SB412 as follows. A conventional method including mutagenesis with nitrosoguanidine and replica plating was not expected to be useful for the identification of such a mutant because the large population of parent-type colonies excrete abundant D-biotin, which in a very small amount will support the growth of biotin-requiring cells. Therefore, we used Mu dl as a tool for mutagenesis. This Mu derivative has an Apr marker and randomly integrates into chromosomes of enteric bacteria, including S. marcescens (53) . We can readily find an Apr marker among Mu dl-infected cells and then screen for biotin-requiring strains. This approach was applied to the isolation of a biotin-requiring derivative of SB412, designated SB412DB, that did not grow on a minimal agar plate containing either dethiobiotin, DAPA, or KAPA, indicating that SB412DB was a bioB strain.
Subsequently, we obtained Bio+ transductants in the cross between 8000 (wild-type) phage and SB412DB. Of 100 transductants, 95 excreted D-biotin and 5 of 95 were tested for D-biotin production by using a medium containing sucrose and urea. These five Bio+ transductants produced about 1 mg of D-biotin per liter on average. This amount was about 1/20 of that obtained for SB412 and 10 times larger than those obtained for Bio+ transductants from the cross between SB412 phage and SIO01. Dethiobiotin synthetase of transductants from strain SB412DB and 8000 phage was constitutively synthesized, and the level of the enzyme was 20 times higher than that of the wild strain. Reference transductants from SB412DB and SB412 phage had the same levels of both D-biotin production and dethiobiotin synthetase activity as those of SB412. These results suggested that SB412DB had acquired no genetic alteration in the entire region except the biotin operon locus, and its transductants from strain 8000 phage might possess the wild-type biotin operon locus and an unknown mutation. This unidentified mutation was probably responsible for the constitutive synthesis of biotin synthetic enzymes and D-biotin overproduction.
The results described above suggested that SB412 contained one or more mutations involved in the biotin overproduction in an unlinked locus or loci, possibly in a repressor gene locus, distant from the biotin operon locus, in addition to mutations in the biotin operon locus. Taking into account the fact that the Bio+ transductants of SI001 (bioB) from SB304 phage did not overproduce D-biotin, this mutation(s) might be that present in SB304. The second mutation carried by SB412 might have occurred in one of the biotin synthetic enzymes since the Bio+ transductants of S1001 from SB412 phage were capable of producing D-biotin.
Effect of acidomycin on the production of D-biotin and dethiobiotin. To know the mode of action of acidomycin, the wilD-type strain, 8000, and the D-biotin-overproducing strain, SB412, were cultured in a medium containing sucrose and urea with the addition of 10 and 100 mg of acidomycin per liter (Table 6) . Under these conditions, acidomycin did not inhibit the growth of either strain. The wild-type strain showed an increase in the production of total biotin compounds in the presence of acidomycin but not an increase in D-biotin, indicating that this strain produced dethiobiotin under these conditions. When SB412 was cultured in the presence of acidomycin, the production of D-biotin decreased significantly but the total amount of D-biotin and dethiobiotin remained unchanged. This result indicated that acidomycin might prevent the formation of D-biotin from dethiobiotin. (17) , but no one has reported acidomycin-resistant mutants derived from E. coli. ot-Dehydrobiotin was reported to function as a false corepressor for the biotin operon (16) . E. coli mutants resistant to a-dehydrobiotin were previously found to excrete D-biotin plus dethiobiotin because of constitutive synthesis of the biotin biosynthetic enzymes (16, 44) . Our S. marcescens mutants resistant to acidomycin were similar to these E. coli mutants in D-biotin excretion and enzyme constitutivity. Ogata et al. (39, 40) and Eisenberg et al. (17) reported that acidomycin inhibited the formation of D-biotin from dethiobiotin by biotin synthetase. Our present study has shown that this was the case in S. marcescens as well. Interestingly, the conversion of dethiobiotin to biotin by SB412, resistant to a high concentration of acidomycin, was markedly inhibited by the addition of a small amount of acidomycin to the medium. This result indicates that the biotin synthetase of SB412 might be similar to that of the wild strain in sensitivity to acidomycin. Namely, the acidomycin resistance of SB412 might depend on the increase of enzyme synthesis but not on an alteration of the catalytic function of biotin synthetase.
DISCUSSION
Eisenberg et al. reported that ao-dehydrobiotin inhibited the growth of E. coli and that mutants resistant to this analog excreted D-biotin (19) . Interestingly, we found that, in S. marcescens, ao-dehydrobiotin did not inhibit the growth of a wild strain but restored the growth of biotin-requiring mutants (data not shown). The replacement of D-biotin with a-dehydrobiotin might be due to the intracellular formation of D-biotin from this analog by hydrogenation, but we cannot exclude a possibility that ot-dehydrobiotin itself functions as a cofactor for biotin enzymes.
In E. coli, the five biotin biosynthetic enzymes are encoded by the biNA, -B, -F, -C, and -D genes, all of which are clustered on a single operon (2, 13) . This operon is divergently transcribed leftwards to the bioA gene and rightwards to the bioB, -F, -C, and -D genes (5, 10, 22, 50) . Both transcriptions are coordinately repressed by the biotinoperon repressor (birA) protein combined with biotin (3, 4, 12, 46) . Some regulatory mutants, excreting D-biotin and derepressed for the biotin biosynthetic enzymes, were reported to have mutations in the promoter-operator region of the biotin operon and birA locus (8, 19, 32, 43) . On the basis of these genetic backgrounds, we analyzed regulatory mutations of D-biotin-producing strains of S. marcescens.
In a biotin-overproducing mutant of S. marcescens, transductional analysis has revealed that SB412 had acquired at least two mutations enhancing D-biotin production. One mutation located in the biotin operon locus (we have recently confirmed the operonal organization in S. marcescens [unpublished data]) and another mutation located in an unlinked locus were found to contribute to D-biotin production of 0.1 and 1 mg/liter, respectively. The transductional and enzymatic analyses indicated that the unlinked mutation was isolated after the first mutagenesis in SB304 and possibly was located in a repressor gene. The second mutation generating SB412 appears to be in the biotin operon locus. We speculated that the combination of the two mutations might be required for the production of 20 mg/liter by SB412. The parent strain of SB412, SB304, produced a smaller amount of D-biotin (5 mg/liter) than SB412, but we observed no significant differences between SB304 and SB412 in the activities of the two biotin biosynthetic enzymes. These findings indicated that the mutation located in the unlinked locus might be involved in the enhancement of the formation of a specific biotin precursor. Further studies are required for elucidating the genetic profile of D-biotin overproduction by strain SB412.
Our future goal is to develop a method amenable to industrial-scale production of D-biotin. Not only will the D-biotin-overproducing mutant be useful in accomplishing this goal, but it will also aid in clarifying the unsolved mechanism of biotin biosynthesis. Very recently, we have cloned the biotin operon from SB304 and obtained SB412 carrying the resultant recombinant plasmid. This genetically engineered strain of SB412 produced abundant D-biotin from sucrose and urea (unpublished data).
